Drug Profile
YKP 1447
Alternative Names: YKP-1358; YKP-1447Latest Information Update: 11 Jan 2016
Price :
$50
*
At a glance
- Originator SK biopharmaceuticals
- Class Alkaloids; Antipsychotics; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists; Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 10 Apr 2008 Preclinical pharmacodynamics and adverse events data presented at the 235th National Meeting of the American Chemical Society (ACS-2008)
- 06 Jul 2004 Phase-I clinical trials of YKP 1358 in Schizophrenia in USA (PO)
- 24 Mar 2004 Preclinical trials of YKP 1358 in Schizophrenia in South Korea (PO)